Prostate Cancer - Results from #25680

Focal therapy for localised unifocal and multifocal prostate cancer: A prospective development study - Abstract June 5, 2012

Relief of urinary symptoms underappreciated benefit of early stage prostate cancer treatment June 5, 2012

Natural orifice translumenal endoscopic radical prostatectomy (NOTES RP): The evolution of the technique - Abstract June 5, 2012

Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: A focus on zoledronic acid - Abstract June 5, 2012

HDR brachytherapy combined with external beam radiation for localised prostate cancer: Early experience from the Sydney Cancer Centre - Abstract June 5, 2012

Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected - Abstract June 4, 2012

Bias due to missing SEER data in D'Amico risk stratification of prostate cancer - Abstract June 4, 2012

The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: A prospective study of 353 patients - Abstract June 4, 2012

Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality - Abstract June 4, 2012

Core length in prostate biopsy: Size matters - Abstract June 4, 2012

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database - Abstract June 4, 2012

Prostate specific antigen levels and prostate cancer detection rates in patients with end stage renal disease - Abstract June 4, 2012

Intermittent hormone therapy for prostate cancer inferior to continuous therapy June 3, 2012

Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse - Abstract June 1, 2012

Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection - Abstract June 1, 2012

Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat - Abstract June 1, 2012

Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands - Abstract June 1, 2012

A workspace-orientated needle-guiding robot for 3T MRI-guided transperineal prostate intervention: Evaluation of in-bore workspace and MRI compatibility - Abstract June 1, 2012

Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial - Abstract June 1, 2012

Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy - Abstract June 1, 2012

Page 1285 of 1435